» Articles » PMID: 39101096

Growth Inhibitory Effect of (manuka) Chloroform Extract on Breast and Liver Cancer Cell Lines

Overview
Date 2024 Aug 5
PMID 39101096
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Research has demonstrated that possesses various therapeutic benefits. This study set out to determine whether or not extracts had any effect on the ability of HepG2 and MCF-7 breast cancer cells to survive.

Materials And Methods: The antiproliferative activity of extracts was explored using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and lactate dehydrogenase assays. The most active fraction was selected to investigate its effects on apoptosis induction using flow cytometry and quantitative real-time polymerase chain reaction. The constituents of this fraction were characterized using GC-MS analysis.

Results: Research demonstrated that the chloroform fraction of (LSCF) significantly impacted the HepG2 and MCF-7 cancer cell lines. Treatment with LSCF led to a notable rise in both early and late apoptotic cells. Furthermore, there was an upregulation in the mRNA levels of P53, Bax, and caspases, while the expression of Bcl-2 mRNA saw a decrease. The analysis of LSCF revealed the primary components to be cis-calamenene, beta-eudesmol, cyclododecane, and alpha-muurolene.

Conclusion: The study showed the promising antiproliferative activity of , suggesting its potential application for cancer treatment.

Citing Articles

Manuka Essential Oil Triggers Apoptosis and Activation of c-Jun N-Terminal Kinase in Fibroblasts and Fibrosarcoma Cells.

Bass N, Parekh M, Satyal P, Soni S, Jacob J, Mack J Molecules. 2024; 29(21).

PMID: 39519810 PMC: 11547341. DOI: 10.3390/molecules29215168.

References
1.
Mamdouh A, Khodeer D, Tantawy M, Moustafa Y . In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma. Life Sci. 2021; 285:119961. DOI: 10.1016/j.lfs.2021.119961. View

2.
Kari S, Subramanian K, Altomonte I, Murugesan A, Yli-Harja O, Kandhavelu M . Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis. 2022; 27(7-8):482-508. PMC: 9308588. DOI: 10.1007/s10495-022-01735-y. View

3.
Hashem S, Ali T, Akhtar S, Nisar S, Sageena G, Ali S . Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomed Pharmacother. 2022; 150:113054. DOI: 10.1016/j.biopha.2022.113054. View

4.
Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

5.
Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B . Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022; 15(1):174. PMC: 9733270. DOI: 10.1186/s13045-022-01392-3. View